These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 9850070)
1. 3-(Iodoacetamido)-benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells. Jiang JD; Davis AS; Middleton K; Ling YH; Perez-Soler R; Holland JF; Bekesi JG Cancer Res; 1998 Dec; 58(23):5389-95. PubMed ID: 9850070 [TBL] [Abstract][Full Text] [Related]
2. Double blockade of cell cycle at g(1)-s transition and m phase by 3-iodoacetamido benzoyl ethyl ester, a new type of tubulin ligand. Jiang JD; Denner L; Ling YH; Li JN; Davis A; Wang Y; Li Y; Roboz J; Wang LG; Perez-Soler R; Marcelli M; Bekesi G; Holland JF Cancer Res; 2002 Nov; 62(21):6080-8. PubMed ID: 12414632 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of microtubule assembly in tumor cells by 3-bromoacetylamino benzoylurea, a new cancericidal compound. Jiang JD; Wang Y; Roboz J; Strauchen J; Holland JF; Bekesi JG Cancer Res; 1998 May; 58(10):2126-33. PubMed ID: 9605756 [TBL] [Abstract][Full Text] [Related]
4. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors. Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695 [TBL] [Abstract][Full Text] [Related]
5. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin. Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098 [TBL] [Abstract][Full Text] [Related]
6. BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo. Kuo CC; Hsieh HP; Pan WY; Chen CP; Liou JP; Lee SJ; Chang YL; Chen LT; Chen CT; Chang JY Cancer Res; 2004 Jul; 64(13):4621-8. PubMed ID: 15231674 [TBL] [Abstract][Full Text] [Related]
7. Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells. Chang JY; Chang CY; Kuo CC; Chen LT; Wein YS; Kuo YH Mol Pharmacol; 2004 Jan; 65(1):77-84. PubMed ID: 14722239 [TBL] [Abstract][Full Text] [Related]
8. Bcl-xL is phosphorylated in malignant cells following microtubule disruption. Poruchynsky MS; Wang EE; Rudin CM; Blagosklonny MV; Fojo T Cancer Res; 1998 Aug; 58(15):3331-8. PubMed ID: 9699663 [TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of A-105972, an antineoplastic agent. Wu-Wong JR; Alder JD; Alder L; Burns DJ; Han EK; Credo B; Tahir SK; Dayton BD; Ewing PJ; Chiou WJ Cancer Res; 2001 Feb; 61(4):1486-92. PubMed ID: 11245455 [TBL] [Abstract][Full Text] [Related]
10. Identification of tubulin as the molecular target of proapoptotic pyrrolo-1,5-benzoxazepines. Mulligan JM; Greene LM; Cloonan S; Mc Gee MM; Onnis V; Campiani G; Fattorusso C; Lawler M; Williams DC; Zisterer DM Mol Pharmacol; 2006 Jul; 70(1):60-70. PubMed ID: 16571652 [TBL] [Abstract][Full Text] [Related]
11. Apoptosis induction via microtubule disassembly by an antitumour compound, pironetin. Kondoh M; Usui T; Nishikiori T; Mayumi T; Osada H Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):411-6. PubMed ID: 10333483 [TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a new tubulin-binding tetrasubstituted brominated pyrrole. Mooberry SL; Weiderhold KN; Dakshanamurthy S; Hamel E; Banner EJ; Kharlamova A; Hempel J; Gupton JT; Brown ML Mol Pharmacol; 2007 Jul; 72(1):132-40. PubMed ID: 17456786 [TBL] [Abstract][Full Text] [Related]
13. Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo. Perchellet EM; Ladesich JB; Magill MJ; Chen Y; Hua DH; Perchellet JP Anticancer Drugs; 1999 Jun; 10(5):489-504. PubMed ID: 10477169 [TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation. Xiao D; Pinto JT; Soh JW; Deguchi A; Gundersen GG; Palazzo AF; Yoon JT; Shirin H; Weinstein IB Cancer Res; 2003 Oct; 63(20):6825-37. PubMed ID: 14583480 [TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis in leukemic cells by the reversible microtubule-disrupting agent 2-methoxy-5-(2',3',4'-trimethoxyphenyl)-2,4,6-cycloheptatrien-1 -one: protection by Bcl-2 and Bcl-X(L) and cell cycle arrest. Gajate C; Barasoain I; Andreu JM; Mollinedo F Cancer Res; 2000 May; 60(10):2651-9. PubMed ID: 10825137 [TBL] [Abstract][Full Text] [Related]
16. Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity. Tinley TL; Randall-Hlubek DA; Leal RM; Jackson EM; Cessac JW; Quada JC; Hemscheidt TK; Mooberry SL Cancer Res; 2003 Jun; 63(12):3211-20. PubMed ID: 12810650 [TBL] [Abstract][Full Text] [Related]
17. Loss of cell cycle control allows selective microtubule-active drug-induced Bcl-2 phosphorylation and cytotoxicity in autonomous cancer cells. Blagosklonny MV; Bishop PC; Robey R; Fojo T; Bates SE Cancer Res; 2000 Jul; 60(13):3425-8. PubMed ID: 10910051 [TBL] [Abstract][Full Text] [Related]
18. Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin. Bai R; Cichacz ZA; Herald CL; Pettit GR; Hamel E Mol Pharmacol; 1993 Oct; 44(4):757-66. PubMed ID: 8232226 [TBL] [Abstract][Full Text] [Related]
19. Rotenone inhibits mammalian cell proliferation by inhibiting microtubule assembly through tubulin binding. Srivastava P; Panda D FEBS J; 2007 Sep; 274(18):4788-801. PubMed ID: 17697112 [TBL] [Abstract][Full Text] [Related]
20. A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule. Liou JP; Hsu KS; Kuo CC; Chang CY; Chang JY J Pharmacol Exp Ther; 2007 Oct; 323(1):398-405. PubMed ID: 17660383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]